Ikena Oncology, Inc.IKNANASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank43
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-48.45M
Near historical average
Percentile
P43
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-48.42M
Historical baseline
PeriodValueYoY Change
2025$-48.45M+11.2%
2024$-54.55M+27.7%
2023$-75.42M-6.4%
2022$-70.90M-107.7%
2021$-34.14M+23.3%
2020$-44.52M-140.7%
2019$-18.49M+54.8%
2018$-40.89M-